U.S. Trade Distributors Stock News

Corteva (NYSE: CTVA), DuPont, and Chemours agreed to a multi-year US$455 million settlement with North Carolina over PFAS claims. The agreement resolves all state claims tied to PFAS emissions and contamination involving the three companies in North Carolina. Settlement terms outline a defined payment schedule and framework for addressing similar PFAS related obligations going forward. This PFAS settlement with North Carolina reshapes Corteva's legacy risk profile and needs to be weighed...

Jabil (JBL) is under fresh regulatory scrutiny after the FDA issued a detailed warning letter citing significant Current Good Manufacturing Practice violations at its Pharmaceutics International sterile injectables facility. At a share price of US$318.08, Jabil has seen a sharp 5.05% 1 day share price return and a 2.42% 7 day share price return, even though the 30 day share price return is down 13.13% and the 90 day share price return is down 17.34%. Total shareholder return of 32.32% year to...

SentinelOne (S) just expanded its Wayfinder Frontier AI Services by adding OpenAI Daybreak models like GPT-5.6-Cyber to help enterprise customers uncover hard to spot security weaknesses and prioritize remediation work. Recent trading tells a mixed story for SentinelOne. The 30 day share price return is down 11.43%, yet the 90 day move is up 33%, with year to date share price gains of 34.9% pointing to momentum that has built over 2026 despite a 5 year total shareholder return that is still...

EverPass Media announced a multi-year deal that expands commercial distribution of Netflix's NFL slate, giving bars and restaurants access to key 2026 games and events, including the Melbourne opener, Thanksgiving Eve, Christmas Day matchups, Week 18, and NFL Honors. Alongside this EverPass Media agreement, Netflix is pushing deeper into theatrical releases with longer runs and reported box office. This shifts part of its model toward traditional film revenue streams and new monetization...

agilon health stock has logged a very large year to date gain, yet the broader valuation checks still flag it as looking cheap on multiple fronts. For anyone tracking that kind of move, the puzzle is whether this run simply catches up with fundamentals or if the current pricing still leaves room for more optimism already baked in. Year to date, agilon health is up about 433%, which puts a spotlight on whether recent enthusiasm already reflects the underlying business quality. The expanded...

Opendoor Technologies has seen its share price fall sharply over the past few years, yet the stock still screens as overvalued on market multiples and only earns a mixed overall value score. For investors, the question is why a business with such a steep share price decline is not screening as a clear bargain. Over the past 5 years, Opendoor Technologies’ share price has declined about 85%, which signals that expectations embedded in the stock have already reset in a major way. The recent...

Novavax presented its licensing-led vaccine and adjuvant strategy at Cantor Fitzgerald's Global Healthcare Conference and Citi's Biopharma Back to School Summit in New York, outlining how partners such as Sanofi and Pfizer are involved in commercialization and development plans. Management highlighted that upfront payments, milestones and technology transfers tied to Matrix-M partnerships are increasingly central to funding research, including early oncology work on "cold" tumors. We will...

A 1.4% pop in Adobe on Friday is a polite clap, not a standing ovation, for what just landed. Traders nudged the stock higher while the actual report shouted something louder. Q3 revenue reached US$6.76b and non GAAP earnings per share came in at US$6.13, both solid for a mature software heavyweight. Yet the real story sat in fast building recurring cash flows. Annualized recurring revenue hit US$27.5b, a figure that speaks directly to durability, even if the short term price move suggests...

Atkore has delivered a strong 56.7% return over the past year, yet valuation checks suggest the stock now trades close to its estimated intrinsic value rather than offering obvious cheapness. The 1 year gain of 56.7% sets a high bar for fresh buyers who are weighing how much of Atkore’s cash flow story is already reflected in the price. Future cash generation from its electrical and infrastructure products can support the current share price, while any pressure on volumes or pricing could...

Hewlett Packard Enterprise stock has logged a very strong five year run, yet both an intrinsic value check and earnings multiples still point to the shares pricing in less than the modelled worth of the business. That mix of a big past gain and lingering valuation gap is what investors now need to weigh. Over the past five years, Hewlett Packard Enterprise has returned about 423.4%, which is a very large gain and sets a high bar for any further upside to feel justified. Heavy demand for...

SoundHound AI (NasdaqGM:SOUN) has appointed former LivePerson chief John Collins as chief financial officer of the combined company. Collins previously served as LivePerson's CFO and interim CEO during the period leading up to SoundHound AI's acquisition of the business. The finance chief is expected to oversee integration of LivePerson's operations and support SoundHound AI's push toward profitability in AI customer service. The Collins CFO appointment after the LivePerson acquisition is...

Designer Brands stock slipped 1.8% to US$5.88 after the earnings release, which might look like a shrug from the market, yet the quarter told a sharper story. This is a retailer often viewed as a low-growth mall staple, but Q2 showed a different picture with adjusted gross margin at 47.9% and adjusted operating income at US$39.4m. The big swing factor was profit quality. A US$20.2m tariff refund lifted results, while underlying assortment and inventory choices did some of the heavy lifting on...

SK hynix (NasdaqGS:SKHY) is back in focus after South Korea’s KOSPI index saw sharp swings this year, with chip heavyweights like SK hynix cited as key drivers of that volatility. Recent moves in SK hynix share price tell a different story from the choppy KOSPI. The stock posted a 1-day share price return of 0.94%, a 7-day share price return of 7.38%, and a punchy 30-day share price return of 23.09%. A 13.13% year to date share price return suggests momentum has been building as investors...

Burning Rock Biotech rose 5.7% today, extending a sharp three-month rally, even though the latest quarter still shows the business firmly in loss-making territory. Traders are reacting to improving top-line scale rather than clean profitability. Revenue for Q2 was ¥134.8m, while the company reported a net loss of ¥18.4m and a basic loss per share of ¥1.70. For anyone looking beyond the next few sessions, the focus is on whether that growing sales base, together with a P/S of 1.8x against far...

Goodyear Tire & Rubber stock has had a rough run over the past few years, yet its current valuation checks still flag it as looking cheap on several fronts. For investors watching a long slide in the share price, the question is whether that discount reflects opportunity or simply the heavy baggage of a highly leveraged, low margin business trying to repair itself. Over the past 5 years, Goodyear Tire & Rubber has declined 68.4%, which signals that the market has significantly marked down...

Star Bulk Carriers has delivered strong share price gains over the past few years, yet the valuation picture today is more nuanced than a simple "cheap" or "expensive" label. The stock screens as undervalued on market multiples, while a mixed overall value score suggests investors need to look closely at what is really priced in. Over the past 5 years, Star Bulk Carriers has returned about 141%, which puts extra weight on whether recent enthusiasm has already captured much of the easy...

Expand Energy stock has nearly doubled over the past five years, yet the broader valuation checks still point to a company that looks cheap rather than fully priced in. Recent share price softness contrasts with a high value score and an undervalued read on market multiples, which puts the current level under closer scrutiny for long term investors. Expand Energy has returned about 96% over five years, which suggests long term holders have already seen solid gains even as the recent trend...

Vail Resorts reported that, after the close of its nomination window, activist investor Oasis Management and other shareholders submitted slates to nominate Robert A. Chapek, M. Ashton Hudson, Bryce Roberts, and Picabo Street for board seats. The company is also conducting a separate search for an additional independent director into early 2027. The contest over board seats highlights how Vail Resorts’ governance is being challenged at the same time the business faces less predictable...

Gilead Sciences (GILD) just saw its herpes simplex virus collaboration with Assembly Biosciences deepen, as Assembly opted into a 40% U.S. cost and profit share on the HSV helicase primase program. The Gilead Sciences share price has climbed 18.19% year to date and 14.44% over the past 90 days, while the 1-year total shareholder return of 28.73% and 3-year total shareholder return above 2x suggest momentum has been building as investors weigh recent product approvals, legal wins and expanded...

XPeng (NYSE:XPEV) reported August 2026 vehicle deliveries of 39,107 units, a 4% year over year increase, giving investors fresh data on how the physical AI focused automaker is converting interest into actual sales. The fresh delivery update comes amid a weak price backdrop for XPeng, with the share price down 10.3% over the past 30 days and 48.4% year to date, while the 1-year total shareholder return has declined 49.5%. This signals that recent momentum has been fading despite improving...

MannKind stock has fallen about 33% year to date, yet several valuation checks, including an intrinsic value estimate using a Discounted Cash Flow (DCF) approach, point to a price that sits below what those models suggest. That gap, combined with mixed signals from broader valuation screens, puts the current share level under closer scrutiny for investors trying to assess what is already priced in. The share price has declined roughly 33% year to date, which means sentiment has cooled...

Amgen (NasdaqGS:AMGN) reported Phase 3 DeLLphi-305 results for IMDELLTRA in first-line maintenance extensive stage small cell lung cancer. The study is described as the first Phase 3 trial to show an overall survival benefit for a BiTE therapy in this setting. Management positioned the positive DeLLphi-305 outcome as a key milestone for Amgen's oncology franchise and treatment options in small cell lung cancer. The DeLLphi-305 survival data for IMDELLTRA adds fresh context to the broader...

The market barely flinched on Yuanbao, with the stock up just 2% today, yet the earnings story was far louder than the price move suggests. You saw a routine green day. The company printed a sharp Q2 headline, with revenue of RMB 1.39b and net income of RMB 413.2m. That left a net margin of 29.7%, a powerful figure for an online insurance platform. In the short term, the share price reaction looks cautious. The gap between that restraint and the strength of the profitability trend is where...

A new global carbon fiber report has put Hexcel (HXL) in focus, naming the producer among leading suppliers to aerospace, wind energy, electric vehicles, hydrogen storage, and recycled carbon markets. Hexcel shares closed at US$92.74 after a 3.25% 1-day share price return, while the stock is still down 9.35% on a 30-day share price basis and 5.09% over 90 days. The 1-year total shareholder return of 50.93% and 5-year total shareholder return of 66.02% indicate momentum that has built over a...